Alex Chen is the President for Overseas Operations and Business Development at uBriGene Biosciences Inc. He is responsible for expanding overseas business and market share. Alex has over 20 years of experience in operational management, investment, acquisitions and strategic partnerships. As part of his responsibilities for managing the North American operations, he oversees corporate projects, commercial developments, and facility operations. Prior to this role, he served as Managing Director of Eastern Capital Inc., where he was responsible for USD $1 billion asset under management portfolio for an array of clients from the mining, commercial and financial services industries. He was also an acting advisor on an investment project for issuing USD $500 million bond for a pharmaceutical company which was listed on the Hong Kong Stock Exchange. Alex also held several leadership positions at Rio Tinto Alcan, RCI Capital Inc., Ministry of Transportation and Infrastructure BC, Worley Parsons and Westmar Advisors. He holds a BSc in Civil Engineering from Hunan University and a Master of Engineering degree from the University of British Columbia (UBC).